SCHEMBL30890630

SCHEMBL30890630

[2H]N1CC[C@]2(C1)Oc1cc(C(=O)N(C)C)ccc1NC2=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 6/20 0.37
▸ ALOX5 P09917 1/20 0.36
▸ IP6K1 Q92551 1/20 0.35
▸ NPY5R Q15761 1/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ CRBN Q96SW2 1/20 0.34
▸ JAK3 P52333 1/20 0.33
▸ POLB P06746 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MMP2 P08253 1/20 0.31
▸ MMP9 P14780 1/20 0.31
▸ MMP8 P22894 1/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ RAF1 P04049 1/20 0.31
▸ HPGD P15428 2/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890770 0.77 LMNA (0.36) POLBLMNAALDH1A1KDM4EGAA
Hydrochloric Acid SCHEMBL27245049 0.74 OTUD7B (0.33) OTUD7BALOX5IP6K1NPY5RCRBN
SCHEMBL27245195 0.72 OTUD7B (0.37) OTUD7BALOX5IP6K1NPY5RCYP2D6
SCHEMBL27245173 0.70 OTUD7B (0.36) OTUD7BALOX5IP6K1NPY5RCRBN
SCHEMBL30890588 0.67 OTUD7B (0.36) OTUD7B
SCHEMBL30890440 0.67 NR1H2 (0.35) OTUD7BIP6K1
SCHEMBL24427665 0.66 USP2 (0.41) ALDH1A1SMN1; SMN2KDM4ERAF1HPGD
SCHEMBL30471207 0.66 BACE1 (0.53) OTUD7BIP6K1JAK3
SCHEMBL24427659 0.63 MAPT (0.37) NPY5RPOLBLMNAALDH1A1SMN1; SMN2
SCHEMBL24427221 0.63 HTT (0.45) POLBALDH1A1SMN1; SMN2KDM4ERAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback